Additional Adjustments. In the event the Company issues any Common Stock or securities exchangeable or convertible into shares of Common Stock after the Warrant Exercisability Date, the Exercise Price shall be reduced so that the aggregate number of shares of Common Stock issued upon exercise of the Note Warrants shall be equal to 10.0% of the issued and outstanding shares of Common Stock immediately following such issuance (determined on a fully diluted and as converted to Common Stock basis assuming full conversion or exercise of all of the Company’s convertible securities and Options, including the Series A-1 Preferred Stock issuable under the Bridge Loan and the Note Warrants, and, excluding the Notes).
Appears in 5 contracts
Samples: Warrant Agreement (NationsHealth, Inc.), Warrant Agreement (NationsHealth, Inc.), Warrant Agreement (NationsHealth, Inc.)
